Arcadia Biosciences Inc Total Liabilities
Arcadia Biosciences Inc total liabilities. Based on the latest financial reports, Arcadia Biosciences Inc (RKDA) has total liabilities worth $2.41 Million USD as of December 2025. Total liabilities represent everything the company owes to external parties, combining both current liabilities—like accounts payable, short-term debt, and accrued expenses—and non-current liabilities such as long-term debt, pension obligations, lease liabilities, and deferred tax liabilities. Check RKDA asset resilience ratio to evaluate the company's liquid asset resilience ratio.
Total Liabilities of Arcadia Biosciences Inc (2012–2025)
Total liabilities of Arcadia Biosciences Inc from 2012 to 2025. This chart illustrates how Arcadia Biosciences Inc's total liabilities have evolved over time, based on quarterly financial data. Explore RKDA long-term investments to assets to see how much of total assets are deployed in long-term investments.
Arcadia Biosciences Inc Competitors by Total Liabilities
The table below lists competitors of Arcadia Biosciences Inc ranked by their total liabilities.
| Company | Country | Total Liabilities |
|---|---|---|
|
Dewhurst plc
LSE:DWHA
|
UK | GBX10.81 Million |
|
Sanco Industries Limited
NSE:SANCO
|
India | Rs687.89 Million |
|
Digital Brands Group, Inc. Common Stock
NASDAQ:DBGI
|
USA | $46.13 Million |
|
Scinai Immunotherapeutics Ltd
NASDAQ:SCNI
|
USA | $5.44 Million |
|
Desarrolladora Homex S.A.B. de C.V
MX:HOMEX
|
Mexico | MX$1.00 Billion |
|
GO.D.M Investments Ltd
TA:GODM
|
Israel | ILA165.00K |
|
Windar Photonics Plc
LSE:WPHO
|
UK | GBX2.79 Million |
|
Recon Technology Ltd
NASDAQ:RCON
|
USA | $91.93 Million |
Liability Composition Analysis (2012–2025)
This chart breaks down Arcadia Biosciences Inc's total liabilities into key components over time: long-term debt, short-term debt, other current liabilities, and other non-current liabilities. Toggle between absolute values and percentage view to see how the composition has shifted. For the complete balance sheet picture, see Arcadia Biosciences Inc (RKDA) total assets.
Liquidity & Leverage Metrics
Arcadia Biosciences Inc Total Liabilities Ratios Explained
Arcadia Biosciences Inc total liabilities ratios compare its liabilities with its current assets, cash and shareholder equity.
| Metric | Value | Description |
|---|---|---|
| Current Ratio | 3.09 | Measures ability to pay short-term obligations (Current Assets ÷ Current Liabilities) |
| Quick Ratio | N/A | More stringent measure of short-term liquidity ((Current Assets - Inventory) ÷ Current Liabilities) |
| Cash Ratio | N/A | Most conservative liquidity measure (Cash & Equivalents ÷ Current Liabilities) |
| Debt to Equity | 0.58 | Measures financial leverage (Total Liabilities ÷ Shareholder Equity) |
| Debt to Assets | 0.37 | Portion of assets financed with debt (Total Liabilities ÷ Total Assets) |
Liability Trends Comparison
This chart compares key liability metrics across different time periods, showing how Arcadia Biosciences Inc's debt structure has evolved. The comparison includes total liabilities, long-term debt, and current liabilities.
Annual Total Liabilities for Arcadia Biosciences Inc (2012–2025)
The table below shows the annual total liabilities of Arcadia Biosciences Inc from 2012 to 2025.
| Year | Total Liabilities | Change |
|---|---|---|
| 2025-12-31 | $2.41 Million | -67.01% |
| 2024-12-31 | $7.29 Million | +4.17% |
| 2023-12-31 | $7.00 Million | -12.72% |
| 2022-12-31 | $8.02 Million | -36.94% |
| 2021-12-31 | $12.72 Million | -32.32% |
| 2020-12-31 | $18.80 Million | -22.48% |
| 2019-12-31 | $24.25 Million | +116.33% |
| 2018-12-31 | $11.21 Million | +30.90% |
| 2017-12-31 | $8.56 Million | -75.09% |
| 2016-12-31 | $34.38 Million | +1.06% |
| 2015-12-31 | $34.02 Million | +27.05% |
| 2014-12-31 | $26.77 Million | -0.24% |
| 2013-12-31 | $26.84 Million | +40.94% |
| 2012-12-31 | $19.04 Million | -- |
About Arcadia Biosciences Inc
Arcadia Biosciences, Inc. produces and markets plant-based food and beverage products in the United States. The company develops crop improvements primarily in wheat to enhance farm economics by improving the performance of crops in the field, as well as their value as food ingredients. Its food, beverage, and body case products include GoodWheat, Zola coconut water, ProVault topical pain relief,… Read more